Biosensors to monitor MS activity. (April 2020)

• Record Type: Journal Article
• Authors: Graves, Jennifer S; Montalban, Xavier
• Other Names: Chitnis Tanuja guest-editor.; Prat Alexandre guest-editor.
• Is Part Of: Multiple sclerosis. Volume 26:Number 5(2020)
• Page Start: 605
• Page End: 608
• Publication Date: 2020-04
• Subjects: Multiple sclerosis -- biosensors -- wearable devices -- digital health; Central nervous system -- Diseases -- Periodicals; Myelin sheath -- Diseases -- Periodicals; Inflammation -- Periodicals; Multiple sclerosis -- Periodicals; Central Nervous System Diseases -- Periodicals; Demyelinating Diseases -- Periodicals; Inflammation -- Periodicals; Multiple Sclerosis -- Periodicals; Système nerveux central -- Maladies -- Périodiques; Gaine de myéline -- Maladies -- Périodiques; Inflammation (Pathologie) -- Périodiques; Sclérose en plaques -- Périodiques; Electronic journals; 616.834005
• DOI: 10.1177/1352458519888178
• Languages: English
• ISSNs: 1352-4585

Abstract

Advances in wearable and wireless biosensing technology pave the way for a brave new world of novel multiple sclerosis (MS) outcome measures. Our current tools for examining patients date back to the 19th century and while invaluable to the neurologist invite accompaniment from these new technologies and artificial intelligence (AI) analytical methods. While the most common biosensor tool used in MS publications to date is the accelerometer, the landscape is changing quickly with multi-sensor applications, electrodermal sensors, and wireless radiofrequency waves. Some caution is warranted to ensure novel outcomes have clear clinical relevance and stand-up to the rigors of reliability, reproducibility, and precision, but the ultimate implementation of biosensing in the MS clinical setting is inevitable.